Menu

Submit Your Innovations Today!

You have until the end of this week (Sept. 21 @ 11:59 PM, EDT) to submit your product to The Scientist's 2012 Top 10 Innovations. Be sure to enter your innovative products!

Aug 29, 2012
The Scientist Staff

The Scientist has already gotten some outstanding submissions to our annual Top 10 Innovations competition, and we'd love to have even more. We've extended the deadline from September 19th to the 21st. If you developed a product, procedure, or software that went on the market or into practice anytime after October 2011, you should join the contest before the end of this Friday, September 21st. We've selected a panel of expert judges to sift through the submissions and pick the 10 best, which will be announced in our December issue.

In years past, we’ve highlighted products like a microscope that can work with the optics contained in a cell phone, knockout rats, and a mini-MRI machine. This year promises to offer up more great innovations, but you'll never know if your product is one of 2012's best if you don't submit it. Answer a few simple questions below to enter your product into the competition.

Create your free online surveys with SurveyMonkey, the world's leading questionnaire tool.

Good luck!

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.